These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 14623169)
21. Poly (DL-lactide-co-glycolide) nanoparticle-based inhalable sustained drug delivery system for experimental tuberculosis. Pandey R; Sharma A; Zahoor A; Sharma S; Khuller GK; Prasad B J Antimicrob Chemother; 2003 Dec; 52(6):981-6. PubMed ID: 14613962 [TBL] [Abstract][Full Text] [Related]
22. Formulation of a novel fixed dose combination of salmeterol xinafoate and mometasone furoate for inhaled drug delivery. Liu S; Watts AB; Du J; Bui A; Hengsawas S; Peters JI; Williams RO Eur J Pharm Biopharm; 2015 Oct; 96():132-42. PubMed ID: 26220015 [TBL] [Abstract][Full Text] [Related]
23. Powder properties and their influence on dry powder inhaler delivery of an antitubercular drug. Sethuraman VV; Hickey AJ AAPS PharmSciTech; 2002; 3(4):E28. PubMed ID: 12916922 [TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics of Inhaled Rifampicin Porous Particles for Tuberculosis Treatment: Insight into Rifampicin Absorption from the Lungs of Guinea Pigs. Garcia Contreras L; Sung J; Ibrahim M; Elbert K; Edwards D; Hickey A Mol Pharm; 2015 Aug; 12(8):2642-50. PubMed ID: 25942002 [TBL] [Abstract][Full Text] [Related]
26. Development and Evaluation of Chitosan Microparticles Based Dry Powder Inhalation Formulations of Rifampicin and Rifabutin. Pai RV; Jain RR; Bannalikar AS; Menon MD J Aerosol Med Pulm Drug Deliv; 2016 Apr; 29(2):179-95. PubMed ID: 26406162 [TBL] [Abstract][Full Text] [Related]
27. In vivo lung deposition and sub-acute inhalation toxicity studies of nano-sized alendronate sodium as an antidote for inhaled toxic substances in Sprague Dawley rats. Sultana S; Ali R; Talegaonkar S; Ahmad FJ; Mittal G; Bhatnagar A Environ Toxicol Pharmacol; 2013 Sep; 36(2):636-647. PubMed ID: 23851119 [TBL] [Abstract][Full Text] [Related]
28. Once-daily and twice-daily dosing of p-aminosalicylic acid granules. Peloquin CA; Berning SE; Huitt GA; Childs JM; Singleton MD; James GT Am J Respir Crit Care Med; 1999 Mar; 159(3):932-4. PubMed ID: 10051275 [TBL] [Abstract][Full Text] [Related]
29. One-step preparation of rifampicin/poly(lactic-co-glycolic acid) nanoparticle-containing mannitol microspheres using a four-fluid nozzle spray drier for inhalation therapy of tuberculosis. Ohashi K; Kabasawa T; Ozeki T; Okada H J Control Release; 2009 Apr; 135(1):19-24. PubMed ID: 19121349 [TBL] [Abstract][Full Text] [Related]
30. Extrapulmonary translocation of ultrafine carbon particles following whole-body inhalation exposure of rats. Oberdörster G; Sharp Z; Atudorei V; Elder A; Gelein R; Lunts A; Kreyling W; Cox C J Toxicol Environ Health A; 2002 Oct; 65(20):1531-43. PubMed ID: 12396867 [TBL] [Abstract][Full Text] [Related]
31. N-acetyltransferase genotypes and the pharmacokinetics and tolerability of para-aminosalicylic acid in patients with drug-resistant pulmonary tuberculosis. Sy SK; de Kock L; Diacon AH; Werely CJ; Xia H; Rosenkranz B; van der Merwe L; Donald PR Antimicrob Agents Chemother; 2015 Jul; 59(7):4129-38. PubMed ID: 25963985 [TBL] [Abstract][Full Text] [Related]
32. Para-aminosalicylic acid: the return of an old friend. Donald PR; Diacon AH Lancet Infect Dis; 2015 Sep; 15(9):1091-1099. PubMed ID: 26277036 [TBL] [Abstract][Full Text] [Related]
33. Spray-dried particles as pulmonary delivery system of anti-tubercular drugs: design, optimization, in vitro and in vivo evaluation. Garg T; Goyal AK; Rath G; Murthy RS Pharm Dev Technol; 2016 Dec; 21(8):951-960. PubMed ID: 26334961 [TBL] [Abstract][Full Text] [Related]
34. Preparation and in vivo evaluation of a dry powder for inhalation of capreomycin. Fiegel J; Garcia-Contreras L; Thomas M; VerBerkmoes J; Elbert K; Hickey A; Edwards D Pharm Res; 2008 Apr; 25(4):805-11. PubMed ID: 17657592 [TBL] [Abstract][Full Text] [Related]
35. Dose regimen of para-aminosalicylic acid gastro-resistant formulation (PAS-GR) in multidrug-resistant tuberculosis. Kibleur Y; Brochart H; Schaaf HS; Diacon AH; Donald PR Clin Drug Investig; 2014 Apr; 34(4):269-76. PubMed ID: 24488376 [TBL] [Abstract][Full Text] [Related]
36. Pulmonary effects of ultrafine and fine ammonium salts aerosols in healthy and monocrotaline-treated rats following short-term exposure. Cassee FR; Arts JH; Fokkens PH; Spoor SM; Boere AJ; van Bree L; Dormans JA Inhal Toxicol; 2002 Dec; 14(12):1215-29. PubMed ID: 12454787 [TBL] [Abstract][Full Text] [Related]
37. Computationally efficient analysis of particle transport and deposition in a human whole-lung-airway model. Part II: Dry powder inhaler application. Kolanjiyil AV; Kleinstreuer C; Sadikot RT Comput Biol Med; 2017 May; 84():247-253. PubMed ID: 27836120 [TBL] [Abstract][Full Text] [Related]
38. Direct lung delivery of a dry powder formulation of DTPA with improved aerosolization properties: effect on lung and systemic decorporation of plutonium. Gervelas C; Serandour AL; Geiger S; Grillon G; Fritsch P; Taulelle C; Le Gall B; Benech H; Deverre JR; Fattal E; Tsapis N J Control Release; 2007 Mar; 118(1):78-86. PubMed ID: 17241685 [TBL] [Abstract][Full Text] [Related]
39. Characterization and pharmacokinetic analysis of crystalline versus amorphous rapamycin dry powder via pulmonary administration in rats. Carvalho SR; Watts AB; Peters JI; Liu S; Hengsawas S; Escotet-Espinoza MS; Williams RO Eur J Pharm Biopharm; 2014 Sep; 88(1):136-47. PubMed ID: 24859653 [TBL] [Abstract][Full Text] [Related]
40. Inhalation of estradiol for sustained systemic delivery. Wang J; Ben-Jebria A; Edwards DA J Aerosol Med; 1999; 12(1):27-36. PubMed ID: 10351127 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]